Summary
This Form 8-K filing from Exelon Corporation, dated April 1, 2010, primarily addresses the financial impact of recently enacted federal healthcare legislation. The key provision affecting Exelon involves a reduction in the deductibility of retiree healthcare costs for federal income tax purposes, contingent on employers receiving federal subsidies for retiree prescription drug benefits. While this change is not immediate, Exelon is required to recognize the full accounting impact in its first quarter 2010 financial statements. Specifically, Exelon expects to record a non-cash after-tax charge of approximately $65 million in Q1 2010 to establish deferred tax liabilities. This charge includes contributions from its subsidiaries: Exelon Generation Company ($24 million), Commonwealth Edison Company ($11 million), and PECO Energy Company ($9 million). Importantly, these charges will be excluded from the company's adjusted (non-GAAP) operating earnings for 2010, providing a clearer view of ongoing operational performance for investors.
Key Highlights
- 1Exelon Corporation (EXC) filed a Form 8-K on April 1, 2010, to report the impact of new federal healthcare legislation.
- 2The legislation reduces the tax deductibility of retiree healthcare costs under certain conditions related to federal subsidies for prescription drug benefits.
- 3Exelon expects to record a non-cash, after-tax charge of approximately $65 million in the first quarter of 2010 for income tax expense.
- 4This charge is to establish deferred tax liabilities resulting from the change in deductibility.
- 5Subsidiaries contributing to the charge include Exelon Generation ($24M), Commonwealth Edison ($11M), and PECO Energy ($9M).
- 6These charges will be excluded from Exelon's 2010 adjusted (non-GAAP) operating earnings.
- 7The company estimates an ongoing annual increase in income tax expense ranging from $10 million to $15 million due to this legislation.